Vogl Matthias
Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Health Economics and Health Care Management, Munich, Germany; Ludwig-Maximilians-Universität München, Munich School of Management, Institute of Health Economics and Health Care Management & Munich Center of Health Sciences, Munich, Germany.
Health Policy. 2014 Apr;115(2-3):141-51. doi: 10.1016/j.healthpol.2014.01.013. Epub 2014 Jan 23.
The paper analyzes the German inpatient capital costing scheme by assessing its cost module calculation. The costing scheme represents the first separated national calculation of performance-oriented capital cost lump sums per DRG.
The three steps in the costing scheme are reviewed and assessed: (1) accrual of capital costs; (2) cost-center and cost category accounting; (3) data processing for capital cost modules. The assessment of each step is based on its level of transparency and efficiency. A comparative view on operating costing and the English costing scheme is given.
Advantages of the scheme are low participation hurdles, low calculation effort for G-DRG calculation participants, highly differentiated cost-center/cost category separation, and advanced patient-based resource allocation. The exclusion of relevant capital costs, nontransparent resource allocation, and unclear capital cost modules, limit the managerial relevance and transparency of the capital costing scheme.
The scheme generates the technical premises for a change from dual financing by insurances (operating costs) and state (capital costs) to a single financing source. The new capital costing scheme will intensify the discussion on how to solve the current investment backlog in Germany and can assist regulators in other countries with the introduction of accurate capital costing.
本文通过评估德国住院资本成本核算方案的成本模块计算来分析该方案。该成本核算方案是首个针对每个疾病诊断相关分组(DRG)按绩效导向单独进行国家层面资本成本总额计算的方案。
对成本核算方案的三个步骤进行审查和评估:(1)资本成本的应计;(2)成本中心和成本类别的核算;(3)资本成本模块的数据处理。对每个步骤的评估基于其透明度和效率水平。给出了与作业成本核算和英国成本核算方案的比较观点。
该方案的优点包括参与门槛低、对于疾病诊断相关分组(G-DRG)计算参与者而言计算工作量小、成本中心/成本类别分离高度差异化以及基于患者的资源分配先进。但排除相关资本成本、资源分配不透明以及资本成本模块不明确,限制了资本成本核算方案的管理相关性和透明度。
该方案为从保险(运营成本)和国家(资本成本)的双重融资转变为单一融资来源创造了技术前提。新的资本成本核算方案将加剧关于如何解决德国当前投资积压问题的讨论,并有助于其他国家的监管机构引入准确的资本成本核算。